MELISSA WIXON: Open Payments
NPI 1255190401 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 21 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $384 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $162 |
| Boston Scientific Corporation | 2 | $56 |
| PFIZER INC. | 2 | $41 |
| MEDICOMP INC | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| BridgeBio Pharma, Inc. | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Medtronic, Inc. | 1 | $14 |
Products named: LEQVIO, LUX-Dx Insertable Cardiac Monitor, TELEPATCH CARDIAC MONITOR, ELIQUIS, Kerendia, VERQUVO, Attruby, ONPATTRO.
Industry payments across NY — which companies pay providers there.
